MEK, Mitogen-Activated Protein Kinase Kinase
Include supporting documentation from your provider, relevant clinical studies, and any evidence that alternative treatments have been tried and failed
How GLP-1 Receptor Agonists Are Transforming Diabetes Care t2diabetesnetwork Jun 23, 2025 7 min read Updated: May 19 Blog Highlights GLP-1 RAs manage blood sugar and support weight loss for T2D and obesity
If you are looking for a simple way to support appetite changes during treatment, GLP-1 Daily Support may be a useful addition to your routine
Morning (30 minutes before breakfast): Lactobacillus reuteri, 10 billion CFU 16 ounces of water With breakfast: Bifidobacterium lactis, 5 billion CFU (increase to 10 billion in week two if tolerated) One serving of fermented food (yogurt, kefir, or sauerkraut) Evening (with dinner): Bifidobacterium longum, 5 billion CFU 3 to 5 grams prebiotic fiber (PHGG or acacia) If experiencing diarrhea, add: Saccharomyces boulardii, 250 mg twice daily Hydration target: 80 ounces minimum daily Track your primary GI symptoms daily on a 1 to 10 scale
Retatrutide Name: Retatrutide Manufacturer: Eli Lilly Current stage: Phase III results expected late 2025/2026 Takeaway: If licensed, it could be more effective for weight loss than other GLP-1s